CapitalStars Financial Research Pvt Ltd

CapitalStars

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Thursday 31 August 2017

Ajanta Pharma launches Eletriptan Hydrobromide Tablets: 31 Aug 2017


Pharma major, Ajanta Pharma, announced that the company has launched Eletriptan Hydrobromide Tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc.

The product was launched in two strengths, 20 mg and 40 mg tablets. The drug is a bioequivalent generic version of Relpax 1 Tablets. It is used to treat migraines. 

Meanwhile, the stock was trading up by 0.37% at Rs 1,197 per share on BSE at 1105 hours. The stock attracted a total traded volume of 2,09,575 shares and traded value of Rs 2,534.31 lakh on NSE at 1107 hours.

The drug is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, the company has 35 Abbreviated New Drug Applications (ANDAs) of which it has 19 final ANDA approvals, 2 tentative approvals, and 14 ANDAs under review with US FDA. So far it has launched 14 products in the US market.

The company’s consolidated revenue for the Q1FY18 remained flat at Rs 473 crore as against Rs 476 crore in corresponding quarter of last year. The PAT for the quarter came in at Rs 94.8 crore, yoy decline of 20.7%.


Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Markets may remain volatile due to Aug series F&O expiry: 31 Aug 2017

Equity Market Outlook

Indian Indices:

Indian equity markets are likely to start trading on a cautious note on Thursday, tracking mixed cues from Asian peers. In the later part of the trading session, markets are expected to witness volatility due to August series F&O expiry. The SGX Nifty, which was trading at 9,869 with a loss of 12 points, is indicating a cautious start for the day.


Now, going forward, on the way up, the index has multiple resistances in the zone of 9,920-9,940, and if it manages to sustain above this resistance area, then it may scale up to the level of 10,000. On the downside, the level of 9,850 is a key support area and the next support is seen around the 9,800 level.


Back home, Indian markets closed higher on Wednesday, with BSE Sensex and Nifty surging about 1%, recovering most of the previous session’s losses as geopolitical tensions eased. The buying in index pivotal such as HDFC twins and Reliance Industries helped the benchmarks recoup their losses.


Global Market:


The US stock market indices ended higher on Wednesday, following the release of some upbeat US economic data, including a report showing a jump in private sector employment. The Dow Jones Industrial Average ended at 21,892 with gains of 27 points. The S&P 500 index jumped 11 points to close at 2,458. The tech-heavy Nasdaq Composite Index climbed 66 points to settle at 6,368. The Nasdaq Composite Index outperformed other benchmarks, the courtesy sharp rise in biotechnology shares.


Asian indices were trading mixed in early trade on Thursday. Japan’s Nikkei 225 has surged 138 points, while Hong Kong's Hang Seng has shed 132 points and China’s Shanghai Composite has slipped 4 points.


Major Headlines of the day:


• Biocon: US FDA target action date for Trastuzumab reset to December 3, US FDA informed Mylan that it will extend target action date for Trastuzumab.

• Reliance Industries: fixed record date for bonus equity shares as September 9.
• Fortis Healthcare sells its stake in Fortis Medicare International Limited to Fortis Global Healthcare.
• Ajanta Pharma gets US FDA nod for Migraine drug, Eletriptan hydro bromide tablet.


Trend in FII flows: The FIIs were net buyers of Rs -12.46 the cash segment on Wednesday while the DIIs were net sellers of Rs 290.78 as per the provisional figures.


Securities in Ban For Trade Date 31-AUG-2017:


1.ADANIENT

2.BEML
3.DLF
4.GMRINFRA
5.HDIL
6.IBREALEST
7.INDIACEM
8.JPASSOCIAT
9.JSWENERGY
10.RELCAPITAL


Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CS OPENING BELL: 31 Aug 2017

CS OPENING BELL

NIFTY SPOT DOWN 5 @9880
SENSEX DOWN 20@31620
BANK NIFTY FUTURES DOWN 58 @24247

CS NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES2: 9955
RES 1:9920
SUP1:9825
SUP2:9775

CS BANK NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES 2: 24525
RES 1:24455
SUP1: 24215
SUP2: 24075

Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Wednesday 30 August 2017

JP Associates, Videocon recover from Monday's fall; Nagarjuna Oil dips 10%: 30 Aug 2017



Shares of JP Associates, Uttam Galva, Ruchi Soya and Videocon recovered on Wednesday after falling up to 10% on Tuesday after reports suggest that these companies were among the 40 names that appeared on RBI's second list of loan defaulters.

These companies may also be sent to NCLT if debt issue is not resolved by mid-December and the list is likely to be released in September, the report says.

JP Associates, which slipped nearly 10% post the development, gained over 7%in Wednesday's trade to Rs 22.95, while SEL Manifacturing and Uttam Galva were up over 3%each in the early morning deals. Videocon Industries also recovered 2%. By comparision, the BSE Sensex was up 0.7%.

Meanwhile, shares of Jai Balaji, Orchid Pharma, Unity Infra and Nagarjuna Oil, extended losses and slipped up to 10% on Wednesday. Nagarjuna Oil tumbled over 10% while Jai Balaji, Orchid Pharma and Unity Infra were down in the range of 4-7%.

In another development, the Reserve Bank of India (RBI), sources say, has instructed banks to maintain the December deadline for completing the bankruptcy proceedings on their largest non-performing assets (NPAs), in addition to the 12 named in June and the ones in various stages of similar operations. 


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Markets open higher: 30 Aug 2017


Indian Indices:

Nifty opened at 9,859 level, down by 63 points while Sensex opened at 31,534 level, up by 146 points. Aurobindo Pharma was top Nifty gainer trading at Rs 747.8 per share, up by 2.29% while NTPC was top Nifty loser trading at Rs 167.3 per share, down by 0.65%. There were 1,135 advances, 294 declines and 486 unchanged stocks on NSE reflecting positive undertone floating in the market.

On the broader markets, BSE Mid-cap index was trading at 15,306 level, up by 0.19% while BSE Small-cap index was trading at 15,707 level, up by 0.33%.

Nifty 50 has major support placed around the levels of 9,740-9,750, and if Nifty sustains below these levels, fresh selling pressure could drag index up to the level of 9,685. On the way up, the level of 9,850-9,860 may act as a stiff resistance level.

Global Market:

The Dow Jones Industrial Average marked its one of the biggest single-day comebacks of the year. The Dow Jones Industrial Average ended 57 points higher at 21,865. The Nasdaq Composite Index surged 19 points to close at 6,302. The S&P 500 edged up 2 points to finish at 2,446.

Asian stock indices were trading on positive territory at the open on Wednesday. Hong Kong's Hang Seng has surged 172 points; Japan’s Nikkei 225 has advanced 99 points and China’s Shanghai Composite has gained 7 points

Major Headlines of the day:

• Amtek Auto: Corporate insolvency resolution process has issued advertising seeking EOI (expression of interest) for Amtek Auto
• Kesar Terminal : has started dispatching first lot of export cargo through 45 container of 40 FEU each, from the Powarkheda (PRKD) station
• Coal India: yet to get a new chairman, current Chairman retires this week: ET-USFDA issues warning letter to Hetero Labs

Trend in FII flows: The FIIs were net buyers of Rs -1459.64 the cash segment on Tuesday while the DIIs were net sellers of Rs 1391.33 as per the provisional figures.

Securities in Ban For Trade Date 30-AUG-2017:

1.BEML
2.DLF
3.GMRINFRA
4.HDIL
5.IBREALEST
6.INDIACEM
7.JSWENERGY
8.JUSTDIAL
9.RELCAPITAL


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CS OPENING BELL: 30 Aug 2017

CS OPENING BELL

NIFTY SPOT UP 72 @9867
SENSEX UP 206@31595
BANK NIFTY FUTURES UP 202 @24310

CS NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES2: 9925
RES 1:9845
SUP1:9755
SUP2:9715

CS BANK NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES 2: 24425
RES 1:24225
SUP1: 24050
SUP2: 23925

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Tuesday 29 August 2017

Gold rebounds on global cues, silver jumps Rs 515/kg: 29 Aug 2017


Gold recovered at the domestic bullion market here on Monday on sustained buying interest from stockists and retailers amid strong global cues.

Silver too reclaimed the Rs 39,000-mark due to speculative offtake amid heavy industrial demand.

Standard gold (99.5 purity) climbed by Rs 335 to close at Rs 29,245 per 10 grams from last Friday’s closing level of Rs 28,910.

Pure gold (99.9 purity) also gained by a similar margin to close at Rs 29,395 per 10 grams against Rs 29,060.

Silver (.999 fineness) rose by Rs 515 per kg to close at Rs 39,225 from Rs 38,710 previously.

In Asian trade, gold rose to its highest in more than a week as the dollar weakened and the euro powered ahead after the head of the European Central Bank refrained from talking down the single currency at a high-profile meeting of central bankers.

Spot gold rose 0.4 per cent to $ 1,296.50 an ounce at early trade, having touched its highest since August 18 at $1,298.58.

In other precious metals, silver was up 0.5 per cent at $17.15 an ounce, having touched its highest since August 18 at $17.21.



Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Markets likely to open lower: 29 Aug 2017

Equity Market Outlook

Indian Indices:

Indian equity markets may open in negative terrain on Tuesday following weak cues prevailing in the Asian peers and after reports of North Korea fired a ballistic missile that flew over Japanese airspace. The SGX Nifty, which was trading at 9,863 down by 50 points, indicate a weak start for the day.  

Nifty50 index after registering up-move for the fourth session in a row, now needs to cross the major hurdle of 9,930-9,940 and if it does sustain above this resistance zone it may extend its up-move up to levels of 9,980-10,020. On the flip side, the region of 9,870-9,980 is an immediate support level and if this support is breached next support stands at 9,840.

Back home, after starting the fresh week on a firm note, Indian markets held firm throughout the session and ended in positive territory for the fourth straight session on Monday. BSE Sensex gained 155 points to close at 31,751 and Nifty surged 56 points to settle above 9,900 mark.

Global Market:

U.S. stocks spent the day oscillating in a narrow range and ended the session little changed on Monday, with the Dow industrial slipping in negative terrain and on the other hand, Nasdaq and the S&P 500 posting marginal gains as investor gauged the effect of Hurricane Harvey that has left parts of the Houston-area underwater. The Nasdaq Composite Index gained 17 points to finish at 6,383 and the S&P scaled up 1 point to finish at 2,444. While the Dow Jones Industrial Average slipped 5 points to close at 21,808.

Asian indices were under pressure in early trade on Tuesday after reports that North Korea fired a ballistic missile that flew over Japanese airspace. Japan’s Nikkei 225 has shed 143 points. Hong Kong’s Hang Seng has lost 122 points and China’s Shanghai Composite is trading flat.  

Major Headlines of the day:

Infosys: The company has informed the bourses that some members of the promoters and promoter group may participate in the proposed buyback.
NTPC: Government has proposed to sell 41.22 crore shares or 5% stake in the company via offer for sale. The floor price is set at Rs 168 per share.
Century Plyboards: The company has acquired additional 2% in Huesoulin wood processing factory increasing its holding to 51%.
Magma Fincorp: The company has acquired 26% stake in Magma ITL Finance from International Tractors Limited.

Trend in FII flows: The FIIs were net buyers of Rs -124.74 the cash segment on Monday while the DIIs were net sellers of Rs 476.26 as per the provisional figures.

Securities in Ban For Trade Date 29-AUG-2017:

1.BEML

2.GMRINFRA
3.HDIL
4.IBREALEST
5.INDIACEM
6.JPASSOCIAT
7.JSWENERGY
8.JUSTDIAL
9.RELCAPITAL


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CS OPENING BELL: 29 Aug 2017

CS OPENING BELL

NIFTY SPOT DOWN50 @9862
SENSEX DOWN 157@31598
BANK NIFTY FUTURES DOWN 115@24260

CS NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES2: 9975
RES 1:9945
SUP1:9850
SUP2:9815

CS BANK NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES 2: 24625
RES 1:24525
SUP1: 24225
SUP2: 24175

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Monday 28 August 2017

Nilekani's return to Infosys: The worst is over for firm, say brokerages: 28 Aug 2017



Infosys gained over 3% in trade on Monday to Rs 941 levels on the National Stock Exchange, after Nandan Nilekani assumed charge as its non-executive chairman over the weekend. The stock hit a high of Rs 953.95 and a low of Rs 938 on the NSE in morning deals. By comparison, the Nifty50 and the Nifty IT indices gained 0.4% and 0.8%, respectively. 

Given the development, brokerages have revised their price target for the stock and suggest that the worst may be over for the company as regards corporate governance issues are concerned. Infosys, they feel, can now get back to focussing on tackling business-related issues.

Here’s is a quick compilation of what leading brokerages and research houses said.

JEFFERIES

Co-founder Nandan Nilekani was appointed Non-exec Chairman of the board, with current Chairman, ex-CEO and two independent members stepping down. 

This brings stability to the board, alleviates acrimony with the founders leading to CEO exit last week and eases concerns of potential CEO candidates, the next step in the repair. Stock remains attractively valued given that the strategic direction remains unquestioned and business momentum sustained, maintain Buy

NOMURA

Nandan Nilekani’s will largely be restricted to oversight, governance and bringing stability to the company. We believe the settling of the tussle between the board and the promoters is a positive, but the recent up-move in the stock price largely factors in this development. 

Overall, we remain cautious on the structural concerns facing the industry and possible growth risks at Infosys, even as the overhang related to the tussle between the board and promoters is largely resolved. The next moves in the stock are likely to be driven by near-term results and CEO selection and assessment of his/her ability to lead Infosys through the technological transformation facing the industry.

CLSA

Nandan Nilekani’s return to Infosys gives it the best start in six years in regaining leadership stability, strategic relevance and resolving cultural battles. The new chair has stepped up the pace of CEO selection, strategic reassessment, and alignment of stakeholders which has positively surprised us. With a likely change in strategic direction at Infosys, better than expected leadership and a low valuation, we think risk-reward has 
improved sharply. 

We upgrade our margin assumptions by ~70bps resulting in a 7% FY19-20CL EPS upgrade and a higher target multiple of 15.5x as the sharp discount to peers seems overdone. We upgrade our rating from underperform to BUY with a new target of Rs 1,070 (from Rs940).

EQUINOMICS RESEARCH

Infosys, as an institution, could attract founder and ex-CEO himself to come back. Nandan Nilekani's comeback is a positive development for the company. In our view, he may succeed in bringing some stability to the top board/management level as he already has adequate experience in dealing with founders, senior management and also institutional investors. We believe, the worst for the company is over and it can now focus on the real problems of the IT industry – poor single digit growth in revenues.

IDBI CAPITAL

We believe that Mr. Nadan Nilekani joining Infosys board as non-executive Chairman on Thursday is a great move amid Dr. Vishal Sikka’s stepping down as MD & CEO just a week earlier. We did not expect such a move to happen so fast. We believe that the worst is over for Infosys and upgrade it to ACCUMULATE from HOLD with a new target price of Rs 988 based on 14x FY19E (13x earlier) and factor the impact of share buyback. We would watch out for 
strategic commentary at Q2FY18 earnings con-call for any further upgrades.


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Nifty, Sensex open higher; Infy top Nifty gainer: 28 Aug 2017

Equity Market Outlook

Indian Indices:

Nifty opened at 9,907 level, up by 50 points while Sensex opened at 160 level, up by 31,756 points. Infosys is top Nifty gainer trading at Rs 947.9 per share, up by 3.92%.Nifty opened at 9,907 level, up by 50 points while Sensex opened at 160 level, up by 31,756 points.

Nifty50 has resistance placed around the level of 9,900 and the next resistance is placed around the level of 9,930. On the way downside, the level of 9,830 is an immediate support level and the next support is seen around 9,770.

Equity benchmarks started off the week on a strong note, with the Nifty reclaiming 9,900 level, largely driven by Infosys. Nifty Midcap gained 0.4 percent as about four shares advanced for every share falling on the exchange.

Infosys surged 4 percent as CLSA upgraded the stock to buy from underperform and raised target price to Rs 1,070 from Rs 940 after co-founder Nandan Nilekani joined the company again as non-executive chairman. CEO choices & strategy should improve, the research house said.

Kotak Mahindra Bank, Eicher Motors, Reliance Industries, Hindalco Industries, Sun Pharma and ONGC were other gainers. Dr Reddy's Labs, Hero MotoCorp, Asian Paints and ITC were under pressure. DLF, Adani Enterprises, Adani Power, Future Enterprises, Suzlon Energy, Ansal Housing, Nestle India, Bajaj Finserv and Bajaj Finance rallied up to 6 percent whereas PC Jeweller, Titan Company, Strides, Wockhardt and Cadila Healthcare were 
under pressure.

The 30-share BSE Sensex was up 154.47 points at 31,750.53 and the 50-share NSE Nifty gained 40.15 points at 9,897.20. There were 922 advances, 409 declines and 492 unchanged stocks on NSE reflecting positive sentiments floating in the market.

Global Market:

The US stocks displayed lacklustre performance on Friday, with Dow and the S&P ending the session just above neutral line with positive bias, while the tech-heavy Nasdaq pulled back into the red terrain. The Dow Jones Industrial Average inched up 30 points to finish at 21,814. The S&P 500 gained 4 points to close at 2,443, while the Nasdaq Composite Index shed 6 points to finish at 6,266.

Majority of the Asian markets were trading in positive territory in early trade on Monday. Hong Kong’s Hang Seng has surged 186 points and China’s Shanghai Composite has gained 22 points, while Japan’s Nikkei 225 has slipped 28 points.

Major Headlines of the day:

• Future Enterprises approves the OFS of shares of its subsidiary co, Future Supply Chain Solutions and participation of the company up to 5 percent of paid up capital of FSCSL.
• Meghmani Organics has incorporated a wholly owned subsidiary namely, Meghmani Agrochemicals on August 23, 2017
• Lumax Auto has signed a JV Agreement with Francisco Albero S.A.U., Spain to manufacture and supply Oxygen Censors to the Indian automotive industry
• REC enters into MOU Maharashtra State Power Generation Co. for extending financial assistance to the tune of 13,000 crore

Trend in FII flows: The FIIs were net buyers of Rs -696.93 the cash segment on Wednesday while the DIIs were net sellers of Rs 1044.38 as per the provisional figures.

Securities in Ban For Trade Date 28-AUG-2017:

1.DLF
2.GMRINFRA
3.HDIL
4.IBREALEST
5.JPASSOCIAT
6.JSWENERGY
7.JUSTDIAL


Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-



* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CS OPENING BELL: 28 Aug 2017

CS OPENING BELL

NIFTY SPOT UP 25 @9885
SENSEX UP 107 @ 31705
BANK NIFTY FUTURES UP 27 @24357

CS NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES2: 9915
RES 1:9885
SUP1:9795
SUP2:9775

CS BANK NIFTY FUTURES (AUG) OVERVIEW

TREND BULLISH
RES 2: 24525
RES 1:24425
SUP1: 24175
SUP2: 24075

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Saturday 26 August 2017

D-Street week ahead: Corrections will continue; have some patience: 26 Aug 2017



The domestic stock market opened in the positive territory but later nosedived due to weak global and local clues, with the InfosysBSE 2.01 % saga being the mood spoiler. The tussle between the owners and professionals came out in the forefront on media. 

The induction of a professional management in LupinBSE 3.87 % some two decades ago and in PidiliteBSE 1.59 % two years ago have all made great wealth for shareholders, but somehow the same was not true in the case of Infosys. 

Hopefully, things will change for the better and whoever new professionals come in should hopefully create wealth like the others. Investors should keep patience and ride the darker side, dawn will come soon at Infosys. 

There is a buzz that Bharat Financials could be merged with IndusInd BankBSE 0.68 %. That may or may not be true, but the truth is every time the stock price discounts such an eventually. 

Bharat Financials is the only stock among MFIs that is flirting with its 52-week high. Others are languishing at their lows. 

News and events with respect to a particular stock often create short-term trading opportunities. The move by Tata GlobalBSE -1.20 % to restructure loss-making operations and launch the Himalayan water brand in the US caused the stock price to jump by a few percentage points. As the market is in directionless mode, this type of trades can help traders move the scorecard forward. 

Events of the week 
In continuation of ‘Operation Cleanup’ at PSU banks, the government has opened more merger possibilities. This will largely help reduce the cost of operations and revalue real estate assets at market values, necessitating lower capital infusion by the government in the PSU banks after such mergers. Otherwise, had each bank been recapitalised individually, capital infusion requirement by the government would have been much higher.Thus, the move has been in the interest of long-term investors. 

Technical Outlook 
On the weekly timeframe charts, a small Doji-shaped hammer formation indicated utter confusion in the market, indicating that it is neither ready to fall nor is it willing to go up, as the market is facing resistance at higher levels. 

The medium-term trend lines have been broken decisively, indicating that the market is currently seeing a phase of correction. The expected bottom for the Nifty50 to settle down appears to be at 9,500. 

All rallies should be taken with a pinch of salt, before initiating long positions. Investors should remain on the sidelines for now. Traders should also remain on the side lines till the market direction gets clear. 

Expectations for the Week 
The market is in a state of pause, which is referred to as timewise correction. Stock-specific price movements are happening largely due to news flow and events. 

The market is seeing huge FPI flow since last few weeks, whereas steady inflows from domestic institutions are holding the market. Signs of jitters are visible too. 

The market will certainly take cues in the near term from the commentaries of two most powerful central bankers, Janet Yellen and Mario Draghi, on their plans to unwind respective central bank balance sheets. 

The world is facing alleviated risk of high valuation and implementation of an impending liquidity suction programme in the form of balance sheet unwinding. 

Another risk the global market is facing is the confrontational attitude of US President Donald Trump. Had he been little cooperative, many issues would have been resolved. Such confrontational attitude is putting at risk his ability to get cooperation from within and outside his party, which is posing a threat to US growth, which eventually can have cascading effects on global markets. 

Investors are advised to stay on the sidelines and wait for the correction to get over. Short bounces should not be considered as beginning of a rally. The Nifty50 closed the week at 9,857, up marginally by 0.2 per cent. 

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide free trial to our client.Join our services and trade with us. 

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647